Cite

HARVARD Citation

    Borgohain, R. et al. (2014). Two‐year, randomized, controlled study of safinamide as add‐on to levodopa in mid to late Parkinson's disease. Movement disorders. 29 (10), pp. 1273-1280. [Online]. 
  
Back to record